PL2443105T3 - Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A - Google Patents

Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A

Info

Publication number: PL2443105T3
Authority: PL; Poland
Prior art keywords: inhibitor; new; pde10a enzyme; phenylimidazole derivatives; phenylimidazole
Prior art date: 2009-06-19

Application number

PL10725373T

Other languages

English (en)

Inventor

Andreas Ritzen

Jan Kehler

Morten Langgård

Jacob Nielsen

John Paul Kilburn

Mohamed M Farah

Original Assignee

H Lundbeck As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-19

Filing date

2010-06-17

Publication date

2015-03-31

2009-06-19 Priority claimed from PCT/DK2009/050134 external-priority patent/WO2009152825A1/en

2010-06-17 Application filed by H Lundbeck As filed Critical H Lundbeck As

2015-03-31 Publication of PL2443105T3 publication Critical patent/PL2443105T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Psychiatry (AREA)
Addiction (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

PL10725373T 2009-06-19 2010-06-17 Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A PL2443105T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PCT/DK2009/050134 WO2009152825A1 (en)	2008-06-20	2009-06-19	Novel phenylimidazole derivatives as pde10a enzyme inhibitors
EP10725373.4A EP2443105B1 (en)	2009-06-19	2010-06-17	Novel phenylimidazole derivative as pde10a enzyme inhibitor
PCT/DK2010/050147 WO2010145668A1 (en)	2009-06-19	2010-06-17	Novel phenylimidazole derivative as pde10a enzyme inhibitor

Publications (1)

Publication Number	Publication Date
PL2443105T3 true PL2443105T3 (pl)	2015-03-31

Family

ID=42321053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10725373T PL2443105T3 (pl)	2009-06-19	2010-06-17	Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A

Country Status (28)

Country	Link
EP (1)	EP2443105B1 (pl)
JP (1)	JP5768044B2 (pl)
AR (1)	AR077144A1 (pl)
AU (1)	AU2010262190B2 (pl)
BR (1)	BRPI1015983A2 (pl)
CA (1)	CA2765750A1 (pl)
CR (1)	CR20110654A (pl)
CY (1)	CY1115971T1 (pl)
DK (1)	DK2443105T3 (pl)
DO (1)	DOP2011000397A (pl)
ES (1)	ES2527216T3 (pl)
GE (1)	GEP20146100B (pl)
GT (1)	GT201100322A (pl)
HR (1)	HRP20141222T1 (pl)
IL (1)	IL216684A (pl)
MA (1)	MA33367B1 (pl)
MX (1)	MX2011013400A (pl)
MY (1)	MY156785A (pl)
NZ (1)	NZ597203A (pl)
PL (1)	PL2443105T3 (pl)
PT (1)	PT2443105E (pl)
SG (1)	SG176680A1 (pl)
SI (1)	SI2443105T1 (pl)
SM (1)	SMT201500003B (pl)
TW (1)	TW201100430A (pl)
UA (1)	UA106378C2 (pl)
WO (1)	WO2010145668A1 (pl)
ZA (1)	ZA201109271B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8133897B2 (en)	2008-06-20	2012-03-13	H. Lundbeck A/S	Phenylimidazole derivatives as PDE10A enzyme inhibitors
TWI501965B (zh)	2008-06-20	2015-10-01	Lundbeck & Co As H	作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
TWI485151B (zh)	2009-12-17	2015-05-21	Lundbeck & Co As H	作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
JO3089B1 (ar) *	2010-11-19	2017-03-15	H Lundbeck As	مشتقات ايميدازول كمثبطات لانزيمات pde10a
US8552045B2 (en)	2010-11-19	2013-10-08	H. Lundbeck A/S	Tricyclic imidazole compounds as PDE10 inhibitors
MX2013009575A (es)	2011-02-18	2014-10-14	Exonhit Therapeutics Sa	Derivados de 6, 7-dialcoxi-3-isoquinolinol sustituidos como inhibidores de fosfodiesterasa 10 (pdei0a).
WO2013034755A1 (en) *	2011-09-09	2013-03-14	H. Lundbeck A/S	Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders
WO2013034758A1 (en) *	2011-09-09	2013-03-14	H. Lundbeck A/S	Substituted triazolopyrazines and uses thereof
JP2014526453A (ja) *	2011-09-09	2014-10-06	ハー・ルンドベック・アクチエゼルスカベット	ピリジン化合物およびそれらの使用
CN103874701A (zh) *	2011-09-09	2014-06-18	H.隆德贝克有限公司	吡啶化合物和其用途
TWI570124B (zh)	2011-12-21	2017-02-11	Ｈ朗德貝克公司	作為ｐｄｅ１０ａ酵素抑制劑的喹啉衍生物
WO2013107856A1 (en) *	2012-01-20	2013-07-25	H. Lundbeck A/S	Imidazole derivatives as pde10a enzyme inhibitors
WO2013127817A1 (en)	2012-02-27	2013-09-06	H. Lundbeck A/S	Imidazole derivatives as pde10a enzyme inhibitors
WO2014071044A1 (en)	2012-11-01	2014-05-08	Allergan, Inc.	Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9200016B2 (en)	2013-12-05	2015-12-01	Allergan, Inc.	Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
BR112020013743A2 (pt) *	2018-11-06	2020-12-01	H. Lundbeck A/S	hemiadipato de 5,8-dimetil-2-[2-(1-metil-4-fenil-1h-imidazol-2-il)-etil]-[1,2,4]triazolo[1,5-a]pirazina
WO2020094592A1 (en) *	2018-11-06	2020-05-14	H. Lundbeck A/S	Compounds for treating negative symptoms and cognitive impairments

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4826833A (en)	1984-01-30	1989-05-02	Pfizer Inc.	6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
IL149106A0 (en)	2001-04-20	2002-11-10	Pfizer Prod Inc	Therapeutic use of selective pde10 inhibitors
US20030032579A1 (en)	2001-04-20	2003-02-13	Pfizer Inc.	Therapeutic use of selective PDE10 inhibitors
FR2824065A1 (fr)	2001-04-26	2002-10-31	Neuro3D	Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
AU2003262023A1 (en)	2002-09-10	2004-04-30	Takeda Pharmaceutical Company Limited	Five-membered heterocyclic compounds
WO2004041258A2 (fr)	2002-10-30	2004-05-21	Neuro3D	Utilisation d’inhibiteurs des phosphodiesterases des nucleotides cycliques, ayant une structure benzodiazepinique en therapie
CA2530114A1 (en)	2003-06-30	2005-01-13	Altana Pharma Ag	Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
KR20060030483A (ko)	2003-06-30	2006-04-10	알타나 파마 아게	Ｐｄｅ10 억제제로서 피롤로디히드로이소퀴놀린
WO2005012485A2 (en)	2003-07-31	2005-02-10	Bayer Pharmaceuticals Corporation	Methods for treating diabetes and related disorders using pde10a inhibitors
JP2007523152A (ja)	2004-02-18	2007-08-16	ファイザー・プロダクツ・インク	キナゾリンおよびイソキノリンのテトラヒドロイソキノリニル誘導体
FR2870539B1 (fr)	2004-05-19	2006-08-04	Greenpharma Sa Sa	Nouvelles methodes et medicaments
EP1755611A1 (en)	2004-06-07	2007-02-28	Pfizer Products Inc.	Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
US20060019975A1 (en)	2004-07-23	2006-01-26	Pfizer Inc	Novel piperidyl derivatives of quinazoline and isoquinoline
AU2005282721A1 (en)	2004-09-03	2006-03-16	Memory Pharmaceuticals Corporation	4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
US20060183763A1 (en) *	2004-12-31	2006-08-17	Pfizer Inc	Novel pyrrolidyl derivatives of heteroaromatic compounds
WO2007098169A1 (en) *	2006-02-21	2007-08-30	Amgen Inc.	Cinnoline derivatives as phosphodiesterase 10 inhibitors
TWI501965B (zh)	2008-06-20	2015-10-01	Lundbeck & Co As H	作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物

2010
- 2010-06-17 WO PCT/DK2010/050147 patent/WO2010145668A1/en not_active Ceased
- 2010-06-17 HR HRP20141222AT patent/HRP20141222T1/hr unknown
- 2010-06-17 BR BRPI1015983A patent/BRPI1015983A2/pt not_active Application Discontinuation
- 2010-06-17 SI SI201030841T patent/SI2443105T1/sl unknown
- 2010-06-17 JP JP2012515356A patent/JP5768044B2/ja not_active Expired - Fee Related
- 2010-06-17 GE GEAP201012536A patent/GEP20146100B/en unknown
- 2010-06-17 NZ NZ597203A patent/NZ597203A/xx not_active IP Right Cessation
- 2010-06-17 EP EP10725373.4A patent/EP2443105B1/en active Active
- 2010-06-17 UA UAA201200499A patent/UA106378C2/ru unknown
- 2010-06-17 MY MYPI2011005865A patent/MY156785A/en unknown
- 2010-06-17 PT PT107253734T patent/PT2443105E/pt unknown
- 2010-06-17 DK DK10725373.4T patent/DK2443105T3/en active
- 2010-06-17 SG SG2011089919A patent/SG176680A1/en unknown
- 2010-06-17 AU AU2010262190A patent/AU2010262190B2/en not_active Ceased
- 2010-06-17 CA CA2765750A patent/CA2765750A1/en not_active Abandoned
- 2010-06-17 PL PL10725373T patent/PL2443105T3/pl unknown
- 2010-06-17 ES ES10725373.4T patent/ES2527216T3/es active Active
- 2010-06-17 MA MA34464A patent/MA33367B1/fr unknown
- 2010-06-17 MX MX2011013400A patent/MX2011013400A/es unknown
- 2010-06-18 AR ARP100102165A patent/AR077144A1/es active IP Right Grant
- 2010-06-18 TW TW099119840A patent/TW201100430A/zh unknown
2011
- 2011-11-29 IL IL216684A patent/IL216684A/en active IP Right Grant
- 2011-12-08 CR CR20110654A patent/CR20110654A/es unknown
- 2011-12-14 GT GT201100322A patent/GT201100322A/es unknown
- 2011-12-15 ZA ZA2011/09271A patent/ZA201109271B/en unknown
- 2011-12-19 DO DO2011000397A patent/DOP2011000397A/es unknown
2014
- 2014-12-19 CY CY20141101071T patent/CY1115971T1/el unknown
2015
- 2015-01-05 SM SM201500003T patent/SMT201500003B/xx unknown

Also Published As

Publication number	Publication date
BRPI1015983A2 (pt)	2016-04-19
CR20110654A (es)	2012-03-09
IL216684A0 (en)	2012-02-29
SMT201500003B (it)	2015-03-05
CY1115971T1 (el)	2017-01-25
GEP20146100B (en)	2014-05-27
MY156785A (en)	2016-03-31
SI2443105T1 (sl)	2015-02-27
IL216684A (en)	2016-03-31
HRP20141222T1 (hr)	2015-02-27
PT2443105E (pt)	2015-01-14
JP2012530086A (ja)	2012-11-29
SG176680A1 (en)	2012-01-30
ES2527216T3 (es)	2015-01-21
NZ597203A (en)	2013-03-28
ZA201109271B (en)	2013-02-27
TW201100430A (en)	2011-01-01
WO2010145668A1 (en)	2010-12-23
CA2765750A1 (en)	2010-12-23
UA106378C2 (ru)	2014-08-26
EP2443105A1 (en)	2012-04-25
AR077144A1 (es)	2011-08-03
JP5768044B2 (ja)	2015-08-26
HK1171446A1 (en)	2013-03-28
AU2010262190B2 (en)	2013-01-31
GT201100322A (es)	2014-02-06
MA33367B1 (fr)	2012-06-01
DOP2011000397A (es)	2012-07-15
MX2011013400A (es)	2012-02-21
EP2443105B1 (en)	2014-10-29
DK2443105T3 (en)	2015-01-12
AU2010262190A1 (en)	2012-01-19

Publication	Publication Date	Title
SMT201600104B (it)	2016-04-29	Inibitore di bromodominio benzodiazepinico
ZA201100109B (en)	2012-03-28	Novel phenylimidazole derivatives as pde10a enzyme inhibitors
SMT201600222B (it)	2016-08-31	Formulazione di anticorpi
SMT201600135B (it)	2016-07-01	Nuovi inibitori della s-nitrosoglutatione riduttasi
SMT201500043B (it)	2015-05-05	Indazoli ossazolo-sostituiti come inibitori di pi13-chinasi
DOP2011000397A (es)	2012-07-15	Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a
SMT201500271B (it)	2016-01-08	Inibitori di neprilisina
EP2272817A4 (en)	2011-12-14	PAI-1 INHIBITORS
LT2313364T (lt)	2021-01-25	Simetrinio dimetilarginino nustatymo būdai
DOP2012000114A (es)	2012-08-15	Inhibidor bromodominio de benzodiazepina
DK2513105T3 (da)	2014-07-14	2-arylimidazolderivater som pde10a-enzyminhibitorer
PL3985979T3 (pl)	2024-06-10	Sposób ustalania jednostki odniesienia
DK2513107T3 (da)	2014-10-13	Heteroaromatiske phenylimidazol-derivater som pde10a-enzyminhibitorer
DK2513106T3 (da)	2014-01-13	Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer
EP2467382A4 (en)	2013-01-02	AMINO-TETRA HYDRO-pyridopyrimidine PDE10 INHIBITORS
AP3342A (en)	2015-07-31	Imidazole derivatives as PDE10A enzyme inhibitors
EP2413941A4 (en)	2012-10-10	Renin Inhibitors
EP2435048A4 (en)	2013-07-10	RADIOACTIVELY MARKED PDE10 HEMMER
LT2506840T (lt)	2021-06-25	Hipoksija sukeliančio faktoriaus inhibitorių naudojimas
EP2621276A4 (en)	2015-10-21	2-ALKOXY-PYRIMIDINE-PDE10 INHIBITORS
ITTO20110268A1 (it)	2011-09-30	Composizione di maquillage.
NO20085145L (no)	2010-06-11	Komponent for kraftforsyningssystem
FI20095056A0 (fi)	2009-01-23	Menetelmä polttoturpeen tuottamiseksi
IT1403462B1 (it)	2013-10-17	Procedimento per la realizzazione di mobili bombati
IT1398649B1 (it)	2013-03-08	Procedimento per la decorazione di superfici